Finance

Lists
CLPBY:OTCMKTS
Coloplast AS Sponsored ADR
$7.17
+0.14%
(+0.010) 1D
Aug 28, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLPBY...
Open
$7.20
High
$7.25
Low
$7.16
Mkt. cap
97.26B
Avg. vol.
183.23K
Volume
72.89K
52-wk high
$10.03
52-wk low
$5.64
Beta
0.75
Shares outstanding
2.10B
No. of employees
17K
Open
$7.20
High
$7.25
Low
$7.16
Mkt. cap
97.26B
Avg. vol.
183.23K
Volume
72.89K
52-wk high
$10.03
52-wk low
$5.64
Beta
0.75
Shares outstanding
2.10B
No. of employees
17K
News stories
From web sources and news partners
Profile
Coloplast A/S is a Danish multinational company that develops, manufactures and markets medical devices and services related to ostomy, urology, continence, and wound care. Wikipedia
About Coloplast AS Sponsored ADR
CEO-
Employees17.2K
Founded1957
HeadquartersHumlebaek, Capital Region of Denmark, Denmark
SectorMedical device
Websitecoloplast.com
Previous reportsAll values in DKK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in DKK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
6.96B
7.04B
7.08B
7.36B
Cost of goods sold
2.20B
2.31B
2.37B
2.45B
Cost of revenue
2.20B
2.31B
2.37B
2.45B
Research and development expenses
249.00M
247.00M
254.00M
281.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.62B
2.64B
2.67B
2.72B
Operating expense
2.79B
2.88B
2.90B
2.98B
Total operating expenses
4.99B
5.19B
5.26B
5.43B
Operating income
1.97B
1.85B
1.82B
1.93B
Other non operating income
-6.00M
42.00M
-188.00M
-
EBT including unusual items
1.56B
1.79B
-1.24B
1.87B
EBT excluding unusual items
1.81B
1.83B
1.78B
1.89B
Income tax expense
680.00M
394.00M
-273.00M
412.00M
Effective tax rate
43.73%
22.00%
21.95%
21.98%
Other operating expenses
-80.00M
-6.00M
-23.00M
-25.00M
Net income
875.00M
1.40B
-971.00M
1.46B
Net profit margin
12.57%
19.84%
-13.71%
19.88%
Earnings per share
4.67
-
6.16
-
Interest and investment income
22.00M
32.00M
149.00M
169.00M
Interest expense
-152.00M
-164.00M
-
-206.00M
Net interest expenses
-130.00M
-132.00M
149.00M
-37.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.20B
2.20B
2.17B
5.29B
Gain or loss from assets sale
2.00M
-
1.00M
-5.00M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps